Record Details

Daptomycin (Cubicin) in patients with complicated skin or soft-tissue infections

Farmeconomia

View Archive Info
 
 
Field Value
 
Title Daptomycin (Cubicin) in patients with complicated skin or soft-tissue infections
 
Creator Sacchi, Viola
 
Subject Pharmacoeconomics; Health economics
—
 
Description Skin and soft-tissue infections (SSTIs) are commonly observed and differ in terms of site and localization, clinical characteristics, and the aetiological agent; these infections are usually caused by Staphylococcus aureus or beta-haemolytic streptococci, and are the most frequent forms of methicillin-resistant S. aureus (MRSA) infections. SSTIs are considered complicated if they involve deeper skin structures (fascia or muscle layers), require significant surgical intervention or arise in the presence of significant co-morbidity. The progressive increase of bacterial resistance, in particular for Gram-positive bacteria infections, to currently used agents is a serious and growing problem, and in particular MRSA, GISA (glycopeptides-insusceptible S. aureus), VRE and GRE (glycopeptides-resistant enterococci) are of concern. There is, therefore, a need for additional agents active against these difficult-to-treat pathogens.
 
Publisher SEEd Medical Publishers
 
Contributor —
 
Date 2008-09-15
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
—
 
Format application/pdf
 
Identifier https://journals.seedmedicalpublishers.com/index.php/FE/article/view/229
10.7175/fe.v9i3.229
 
Source Farmeconomia. Health economics and therapeutic pathways; Vol 9, No 3 (2008); 163-166
2240-256X
 
Language eng
 
Relation https://journals.seedmedicalpublishers.com/index.php/FE/article/view/229/218
 
Coverage —
—
—
 
Rights Copyright (c) 2008 Farmeconomia. Health economics and therapeutic pathways
http://creativecommons.org/licenses/by-nc/4.0